About
Looking for more information?
Contact our responsive and friendly client services team any time.
(03) 9028 2888
clients@freshequities.com
Investor presentation - Bioxyne Limited
Bioxyne Limited
Health
Bioxyne Limited (BXN) is an Australian life science, health and medical technology company with a focus on immune health and immunotherapeutic products. Bioxyne has a strategic investment in the consumer dietary supplements and functional foods markets through its proprietary probiotic, Lactobacillus fermentum PCC. Former Names VRI Biomedical Ltd; Probiomics Limited (PCC), 5/04/2012
Read moreMarket Cap
$8.96m
Price at Close
$0.014
4w avg. Volume
280.86k
4w avg. Turnover
$3.73k
Announcements
| announcement | t+2 movement | date |
|---|---|---|
| 0.00% | 26 Nov 2020 |
| 0.00% | 28 Oct 2020 |
| 0.00% | 27 Oct 2020 |
| 0.00% | 30 Sep 2020 |
| 0.00% | 30 Sep 2020 |
| 0.00% | 30 Aug 2020 |
| -22.22% | 20 Aug 2020 |
| -21.43% | 30 Jul 2020 |
| 0.00% | 01 May 2020 |
| 0.00% | 30 Apr 2020 |
Market Data
Current Price
$0.014
52WK HIGH
$0.024
52WK LOW
$0.007
1YR RETURN
-17.65%
1YR RETURN VS. SECTOR
-57.91%
90 DAY RETURN
-6.67%
ASX RANK
1,845
/2,048
SECTOR RANK
163
/168
SHARES OUTSTANDING
640.15m
Bioxyne Limited
Health
Bioxyne Limited (BXN) is an Australian life science, health and medical technology company with a focus on immune health and immunotherapeutic products. Bioxyne has a strategic investment in the consumer dietary supplements and functional foods markets through its proprietary probiotic, Lactobacillus fermentum PCC. Former Names VRI Biomedical Ltd; Probiomics Limited (PCC), 5/04/2012
Read moreMarket Cap
$8.96m
Price at Close
$0.014
4w avg. Volume
280.86k
4w avg. Turnover
$3.73k
ASX:BXN is not raising right now
Want to invest?
Contact Us
(03) 9028 2888
clients@freshequities.com
Address
Level 7, 388 Bourke St
Melbourne VIC 3000
Australia